Health Care/Hospital

COVID-19 Fibroblast Based Cell Therapy Candidate Shown to Reduce Lung Scarring in Aggressive Animal Model

FibroGenesis Advances Preclinical Data in Preparation for FDA Investigational New Drug Submission HOUSTON, July 21, 2020 /PRNewswire/ -- FibroGenesis announced today new data supporting use of its PneumoBlast™ product in the battle against COVID-19. Using the widely accepted bleomycin model of l...

2020-07-21 22:08 2958

Saint Luke's Health System signs with Clinch to accelerate and streamline hiring

NEW YORK, July 21, 2020 /PRNewswire/ -- Saint Luke's Health System has engaged Clinch , a PageUp company, to provide recruitment marketing solutions including a new career site for theirMissouri-based a...

2020-07-21 22:07 2084

Surgere: AutoSphere Gains Altitude - Faster Than Ever

CLEVELAND and TOKYO and ANTWERP, Belgium and AGUASCALIENTES, Mexico, July 21, 2020 /PRNewswire/ -- The Surgere Automotive Supply Chain Community has reached record numbers. The community's amazing growth includes 136 sites in theNorth America and 64 sites in Asia Pacific since January 2020. AutoS...

2020-07-21 22:07 3557

GenScript launches CDMO segment "GenScript ProBio" at inaugural GenScript Cell and Gene Therapy Industry Development & Cooperation Forum

SHANGHAI, July 21, 2020 /PRNewswire/ -- The inaugural GenScript Cell and Gene Therapy Industry Development & Cooperation Forum successfully concluded in Shanghai on July 17, at which more than 700 authoritative researchers and corporate leaders shared insights on the future growth of the cell and ...

2020-07-21 22:04 2663

Ortho Care(TM) Again Ranks No. 1 for Service in Diagnostics Industry

RARITAN, N.J., July 21, 2020 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics with a worldwide reputation for top-rated customer service and support, today announced that its Ortho Care™ holistic service and support program was ranked No. 1 in the diagnostics in...

2020-07-21 22:00 2813

Clarity Pharmaceuticals and ImaginAb to Collaborate on New Cancer Targets

SYDNEY and LOS ANGELES, July 21, 2020 /PRNewswire/ -- Clarity Pharmaceuticals, a radiopharmaceutical company focused on the treatment of serious disease, and ImaginAb, Inc., a company that harnesses the specificity of monoclonal antibodies, have entered into a collaboration agreement to develop n...

2020-07-21 21:13 2055

Samsung Biologics Posts Strong Second Quarter Earnings With 48.5% Increase In Sales

INCHEON, South Korea, July 21, 2020 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announced today strong financial results for its fiscal 2020 second quarter endingJune 30, 2020, maintaining steady business performance with a high operating margin at 26.4%.

2020-07-21 20:20 16779

LifeSignals Wireless Medical Biosensor LP1250 receives FDA clearance

World's first single-use two channel ECG and heart rate biosensor provides 72- hour patient monitoring with remote data access in ambulatory, hospital and home settings FREMONT, Calif., July 21, 2020 /PRNewswire/ -- LifeSignals Group, today announced USFDA 510(k) clearance has been received for ...

2020-07-21 19:00 4297

NICHIBAN to Establish European Subsidiary "NICHIBAN EUROPE GmbH" in Germany

TOKYO, July 21, 2020 /PRNewswire/ -- NICHIBAN CO., LTD., based in Tokyo, announced that it will open a new European subsidiary, "NICHIBANEUROPE GmbH" in Dusseldorf, Germany, in October 2020. As part of the expansion of the company's overseas business, NICHIBAN opened a representative office inDu...

2020-07-21 13:00 1928

BELKIN Laser Finalizes Series B Funding Totalling $12.25M

One-Second Glaucoma Laser Treatment nearing reality for millions of Glaucoma patients YAVNE, Israel, July 21, 2020 /PRNewswire/ -- BELKIN Laser, the Israel-based start-up offering a 1-second, non-invasive glaucoma laser treatment announced today that it has finalized its round B financing with a...

2020-07-21 12:08 2693

Samsung Biologics Expands Drug Product Manufacturing Facility in Incheon

SONGDO, South Korea, July 20, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) announced a plan to expand its Drug Product (DP) capability in line with increasing market demand and to ensure flexible production capabilities for new and existing clients.

2020-07-21 10:13 15999

D-Link Launches Group Temperature Screening Camera Kit with AI Facial Recognition

TAIPEI, July 20, 2020 /PRNewswire/ -- D-Link today announced the new DCS-9500T Group Temperature Screening Camera Kit that can simultaneously scan up to 30 people with a rapid response time within 30 ms, eliminating queues i...

2020-07-21 10:00 2194

D-Link Launches Group Temperature Screening Camera Kit with AI Facial Recognition

TAIPEI, July 21, 2020 /PRNewswire/ -- D-Link today announced the new DCS-9500T Group Temperature Screening Camera Kit that can simultaneously scan up to 30 people with a rapid response time within 30 ms, eliminating queues i...

2020-07-21 10:00 2633

China NMPA Accepts NDA Submission of Ripretinib for Advanced Gastrointestinal Stromal Tumor

SHANGHAI and SAN FRANCISCO and WALTHAM, Mass., July 20, 2020 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB) and Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that the China National Medical Products Administration (NMPA) has accepted its New Drug Application (NDA) for ripretinib...

2020-07-20 22:39 4739

JW Therapeutics Acquires Syracuse Biopharma and Its in-Licenses With Eureka Therapeutics' Solid Tumor Technologies in China

SHANGHAI and EMERYVILLE, Calif., July 20, 2020 /PRNewswire/ -- JW Therapeutics , a clinical stage biopharmaceutical company focused on developing, manufacturing and commercializing cell therapies for patients inChina, today announced the acquisition of Syracuse Bio...

2020-07-20 21:33 4602

PHASE Scientific Announces CE Mark Approval for the PHASIFY(TM) VIRAL RNA Extraction Kit

GARDEN GROVE, Calif., July 20, 2020 /PRNewswire/ -- PHASE Scientific, a fast-growing biotechnology company, announces today it has received the Conformité Européene (CE) Mark approval for its PHASIFY™ VIRAL RNA Extraction Kit. The CE marking confirms that PHASIFY™ VIRAL complies with the European...

2020-07-20 21:00 2003

Connect Biopharma Initiates Phase 2 Clinical Trial of CBP-201 in Adult Patients with Moderate-to-Severe Atopic Dermatitis

SAN DIEGO and TAICANG, SUZHOU, China, July 20, 2020 /PRNewswire/ -- Connect Biopharma, a clinical-stage biopharmaceutical company focused on identifying and developing potent and specific immune modulating molecules, today announced that the first patient has been dosed in a Phase 2 clinical tria...

2020-07-20 20:00 2772

VitaDairy - the No. 1 colostrum company in Vietnam help people strengthening the immune system to contribute fighting off COVID-19

HO CHI MINH CITY, Vietnam, July 20, 2020 /PRNewswire/ -- Vietnam has been one of the countries that have well managedCOVID-19 pandemic with only 383 cases, and no deaths have been reported (updated on 20th July). Immune Nutrition from ColosIgG 24h colostrum is one of the factors contribute fighti...

2020-07-20 18:35 3042

Singapore Kindness Movement and BETADINE(R) support the distribution of care packages to over 1700 General Practitioners

SINGAPORE, July 20, 2020 /PRNewswire/ -- Amidst the global COVID-19 pandemic, over 1700 children spread a little warmth towards General Practitioners in 853 Public Health Preparedness Clinics (PHPC) island-wide, by dedicating care packages to these frontline doctors. Singapore Kindness Movement...

2020-07-20 17:16 4381

New Medical Findings From 10-year Study of 3D Printed Regenerative Implant Osteoplug

SINGAPORE, July 20, 2020 /PRNewswire/ -- Osteopore International Pte Ltd, a global leader in regenerative implants, today revealed new data that demonstrates the long-term safety and efficacy of Osteoplug, a 3D printed bioresorbable polycaprolactone (PCL) bone graft implant, that enables the reg...

2020-07-20 14:41 3719
1 ... 747748749750751752753 ... 848

Week's Top Stories